MYLAN PHARMS INC FDA Approval ANDA 204004

ANDA 204004

MYLAN PHARMS INC

FDA Drug Application

Application #204004

Application Sponsors

ANDA 204004MYLAN PHARMS INC

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET;ORAL600MG;300MG0EPZICOMABACAVIR;LAMIVUDINE

FDA Submissions

ORIG1TA2016-01-15

Submissions Property Types

ORIG1Null0

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204004
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EPZICOM","activeIngredients":"ABACAVIR;LAMIVUDINE","strength":"600MG;300MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/15\/2016","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-01-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.